Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
August 19 2019 - 1:00AM
Business Wire
- PRECISION1 is the first mainstream daily disposable contact
lens to use SMARTSURFACE Technology to deliver lasting visual
performance and comfort1
- New clinical data show five times more contact lens wearers
“strongly preferred” PRECISION1 vs. 1-Day ACUVUE Moist2
- Initial U.S. launch of PRECISION1 begins in September, with
wide availability in early 2020
Regulatory News:
Alcon, the global leader in eye care, today announced plans to
launch the newest addition to its robust contact lens portfolio –
PRECISION1® daily disposable, silicone hydrogel (SiHy) contact
lenses – in the U.S. PRECISION1 is the first-and-only contact lens
with Alcon’s proprietary SMARTSURFACE® technology – a permanent,
micro-thin, high-performance layer of moisture at the lens surface
that helps support a stable tear film to deliver lasting visual
performance from morning to night.1,2
A new head-to-head clinical study demonstrated superiority of
PRECISION1 over top-selling 1-Day ACUVUE^ Moist contact lenses in
attributes critical for successful contact lens wear: vision,
comfort and handling. Study findings showed contact lens wearers
rated PRECISION1 significantly better than 1-Day ACUVUE Moist on
end-of-day vision, end-of-day comfort and overall handling.2*
Moreover, five times more wearers in the study “strongly preferred”
PRECISION1 over 1-Day ACUVUE Moist.2
"PRECISION1 is designed to provide lasting visual performance
for patients who wear their contact lenses from early morning to
late at night,” said David Endicott, Chief Executive Officer,
Alcon. “PRECISION1 will be well-positioned as a mainstream daily
disposable that complements our premium DAILIES TOTAL1® and
value-driven DAILIES® AquaComfort PLUS® contact lenses, further
expanding our contact lens portfolio to give us long-term growth
opportunities in 2020 and beyond as we continue to develop our
promising pipeline.”
PRECISION1 was designed to address the common reasons why 1-in-5
new wearers discontinue contact lens wear within the first year:
poor vision, poor comfort and handling issues.3 The lenses help new
daily disposable contact lens wearers overcome these issues by
providing precise vision, long-lasting comfort and ease of
handling. It also introduces a new lens material – verofilcon A
with Class 1 ultraviolet-blocking capabilities (the highest level
available) – created specifically for PRECISION1 by Alcon Research
and Development.
“With the launch of PRECISION1, we now have a daily disposable
contact lens option that meets the needs of a broad group of
patients and delivers an outstanding wearing experience compared to
similarly priced daily lenses,” said Katie Spear, OD, JD, MPH,
Florida-based optometrist. “PRECISION1 is a lens patients can start
in and stay in for years to come, especially those who have active
lifestyles that demand exceptional all-day performance.”
Alcon’s commercial sales teams will immediately begin working
with select Eye Care Professionals to prepare for initial patient
availability beginning in September. PRECISION1 will become widely
available across the U.S. in early 2020 and will be priced
competitively between DAILIES TOTAL1 and DAILIES AquaComfort PLUS
lenses.
In March 2019, Alcon launched PRECISION1 contact lenses in
Australia and New Zealand, and expects to launch these lenses in
additional markets around the globe throughout 2020 and 2021.
*Based on mean subjective ratings from a prospective,
randomized, bilateral crossover, double-masked, controlled clinical
trial of PRECISION1 and 1-Day ACUVUE MOIST contact lenses;
p≤0.0001. ^Trademarks are the property of their respective
owners.
Cautionary Note Regarding
Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. In particular, our
expectations could be affected by uncertainties regarding the
success of our separation and spin-off from Novartis. Should one or
more of these uncertainties or risks materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those anticipated. Therefore, you should not rely
on any of these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date of its filing, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with Eye Care Professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
References
- Alcon data on file, 2018.
- Alcon data on file, 2019.
- Sulley A, Young G, Hunt C, et al. Retention rates in new
contact lens wearers. Eye & Contact Lens.
2018;44:S273-S282
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190818005025/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Kimberly Wise + 1 817 615 5092 (direct) + 1 817 525 3409
(mobile) kimberly.wise@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024